Skip to content
healthcare.dev
Get a free key

Inmazeb

NDC 61755-018, atoltivimab, maftivimab, and odesivimab-ebgn, injection, solution, from Regeneron Pharmaceuticals, Inc..

Product NDC
61755-018
Status
Listed
Labeler
Regeneron Pharmaceuticals, Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761169
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/61755-018 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATOLTIVIMAB241.7 mg/14.5mL
  • MAFTIVIMAB241.7 mg/14.5mL
  • ODESIVIMAB241.7 mg/14.5mL
Package NDCNDC-11Package
61755-018-01617550018011 VIAL, SINGLE-DOSE in 1 CARTON (61755-018-01) / 14.5 mL in 1 VIAL, SINGLE-DOSE (61755-018-00)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0536b6fe-6fe5-4fd6-8cc6-1b481945c1fa

Use it

Look up 61755-018 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/61755-018 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 61755-018. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.